CSIMarket



Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Free Cash Flow Growth by Quarter and Year

Merck And Co Inc 's Free Cash Flow results by quarter and year




MRK Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 5,095.00 4,006.00 4,794.00
III Quarter September - 4,797.00 2,173.00 4,226.00
II Quarter June - 1,439.00 3,367.00 3,084.00
I Quarter March 4,761.00 1,791.00 707.00 1,336.00
FY   4,761.00 13,122.00 10,253.00 13,440.00



MRK Free Cash Flow first quarter 2022 Y/Y Growth Comment
Merck and Co Inc achieved in the first quarter 2022, above Company average Free Cash Flow surge of 165.83% year on year, to $ 4,761.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 6 other companies have achieved higher Free Cash Flow growth. While Merck And Co Inc ' s Free Cash Flow doubling of 165.83% ranks overall at the positon no. 164 in the first quarter 2022.




MRK Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 27.18 % -16.44 % 33.46 %
III Quarter September - 120.75 % -48.58 % 51.31 %
II Quarter June - -57.26 % 9.18 % -8.81 %
I Quarter March 165.83 % 153.32 % -47.08 % 15.67 %
FY   - 27.98 % -23.71 % 23.05 %

Financial Statements
Merck And Co Inc 's first quarter 2022 Free Cash Flow $ 4,761.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2021 Free Cash Flow $ 1,791.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Free Cash Flow Growth >>


MRK Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 6.21 % 84.35 % 13.44 %
III Quarter September - 233.36 % -35.46 % 37.03 %
II Quarter June - -19.65 % 376.24 % 130.84 %
I Quarter March -6.56 % -55.29 % -85.25 % -62.81 %
FY (Year on Year)   - 27.98 % -23.71 % 23.05 %




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #12
Overall #164

Free Cash Flow Y/Y Growth Statistics
High Average Low
2447.86 % 61.34 % -100 %
(Sep. 30, 2010)   (Dec 31 2011)
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #7
Healthcare Sector #12
Overall #164
Free Cash Flow Y/Y Growth Statistics
High Average Low
2447.86 % 61.34 % -100 %
(Sep. 30, 2010)   (Dec 31 2011)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
1059.79 % 57.95 % -100 %
(Jun 30 2017)  


MRK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Merck And Co Inc reported decline in Free Cash Flow from the previous quarter by -6.56% to $ 4,761.00 millions, from $ 5,095.00 millions declared a quarter before.

If you look into recent downturn in the I. Quarter 2022, you must take into consideration, that commonly I. Quarter Free Cash Flow emerge softer then in the forth quarter

Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Merck And Co Inc 's Free Cash Flow growth quarter on quarter, overall rank is 560.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #36
Overall #560
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #17
Healthcare Sector #36
Overall #560
Free Cash Flow Q/Q Growth Statistics
High Average Low
1059.79 % 57.95 % -100 %
(Jun 30 2017)  


MRK's I. Quarter Q/Q Free Cash Flow Comment
In the I. Quarter 2022 Merck And Co Inc realized decline in Free Cash Flow from the previous quarter by -6.56% to $ 4,761.00 millions, from $ 5,095.00 millions achived in the previous reporting period.

As we look into current shortcoming in the quarter, we must presume, that commonly I. Quarter performance emerge weaker then in the forth quarter, Pranav Dutta , Healthcare sector veteran situated in Bengaluru said.

Within Major Pharmaceutical Preparations industry 16 other companies have achieved higher Free Cash Flow quarter on quarter growth. While Merck And Co Inc 's Free Cash Flow growth quarter on quarter, overall rank is 560.


Merck And Co Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 20,390.00 $ 17,570.00 $ 16,787.00 $ 14,507.00 $ 16,169.00
Y / Y Free Cash Flow Growth (TTM) 26.11 % 17.63 % 9.38 % -13.87 % -3.03 %
Year on Year Free Cash Flow Growth Overall Ranking # 555 # 1015 # 1261 # 976 # 850
Seqeuential Free Cash Flow Change (TTM) 16.05 % 4.66 % 15.72 % -10.28 % 8.25 %
Seq. Free Cash Flow Growth (TTM) Overall Ranking # 337 # 1021 # 762 # 1579 # 562




Cumulative Free Cash Flow growth Comment
Merck And Co Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 26.11% year on year, to $ 20,390 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 22.67% and higher than 17.63% growth in Dec 31 2021.
But sequential rise was slower at 16.05 % from $17570 millions recorded in the period from Dec 31 2021 to Mar 31 2021.
Still it was evidence of positive momentum, while the usual sequential advancement is at 3.69%.
The growth was even stronger from the previous reporting period exhibited at 16.05 % rise from $17570 millions in the period from Dec 31 2021 to Mar 31 2021.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 555, from total ranking in previous quarter at 1015.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
83.46 %
3.69 %
-48.73 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 30
Overall # 555

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
481.43 %
22.67 %
-77.14 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 28
S&P 500 # 337
Cumulative Free Cash Flow growth Comment
Merck And Co Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 26.11% year on year, to $ 20,390 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 22.67% and higher than 17.63% growth in Dec 31 2021.
But from the previous reporting period rise was slower at 16.05 % from $17570 millions achieved in twelve months ending a quarter before.
In spite of, this was confirmation of convincing trend, as the average sequential Free Cash Flow gain lays at 3.69%.
The momentum is even stronger from twelve months ended Dec 31 2021 showed at 16.05 % jump from $17570 millions in the period from Dec 31 2021 to Mar 31 2021.

Within the Healthcare sector 29 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Total ranking has impoved so far to 555, from total ranking in previous quarter at 1015.

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
83.46 %
3.69 %
-48.73 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 30
Overall # 555

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
481.43 %
22.67 %
-77.14 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 28
S&P 500 # 337




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
MRK's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for MRK's Competitors
Free Cash Flow Growth for Merck And Co Inc 's Suppliers
Free Cash Flow Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Free Cash Flow decline for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Adapthealth Corp 261.54%$ 261.540 millions
United Therapeutics Corporation221.49%$ 221.492 millions
Regeneron Pharmaceuticals Inc 214.39%$ 214.390 millions
Owens and Minor Inc 213.49%$ 213.492 millions
Merck and Co Inc 165.83%$ 165.829 millions
Dexcom Inc 155.40%$ 155.396 millions
Pacira Biosciences inc 154.76%$ 154.755 millions
Repligen Corp149.55%$ 149.547 millions
Apollo Medical Holdings Inc 141.54%$ 141.539 millions
Glaukos Corp133.94%$ 133.940 millions
Harmony Biosciences Holdings inc 130.26%$ 130.263 millions
Amphastar Pharmaceuticals Inc 122.41%$ 122.410 millions
Catalyst Pharmaceuticals Inc 122.29%$ 122.286 millions
Reynolds Consumer Products Inc 111.11%$ 111.111 millions
Davita Inc 108.81%$ 108.805 millions
Hologic Inc92.36%$ 92.358 millions
Eventbrite Inc 89.75%$ 89.746 millions
Meridian Bioscience Inc 85.81%$ 85.809 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ZCMD's Profile

Stock Price

ZCMD's Financials

Business Description

Fundamentals

Charts & Quotes

ZCMD's News

Suppliers

ZCMD's Competitors

Customers & Markets

Economic Indicators

ZCMD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071